https://www.selleckchem.com/peptide/gsmtx4.html
We found that serum expression of hsa_circ_0054633 was dramatically increased in patients with T2DM. Serum hsa_circ_0054633 levels had high sensitivity (75.0%) and specificity (95.5%) for differentiating T2DM. Besides, serum expression of circ_0054633 was significantly correlated with fasting blood glucose ( =0.698), hemoglobin A1c ( =0.503) and low-density lipoprotein ( =0.399). Serum hsa_circ_0054633 is a potential noninvasive biomarker in discerning T2DM and is associated with changes in blood glucose and lipid. Serum hsa_circ_0054633
Curtir
Comentario
Compartilhar
